Evidence map›Paper›PMID 37232891›Full record

ArticleBiosensors2023

Gold vs. Silver Colloidal Nanoparticle Films for Optimized SERS Detection of Propranolol and Electrochemical-SERS Analyses.

Cristina M Muntean, Denisa Cuibus, Sanda Boca, Alexandra Falamas, Nicoleta Tosa, Ioana Andreea Brezeştean, Attila Bende, Lucian Barbu-Tudoran, Rebeca Moldovan, Ede Bodoki and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Cristina M MunteanNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Str., 400293 Cluj-Napoca, Romania.
Denisa CuibusNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Str., 400293 Cluj-Napoca, Romania.ORCID 0000-0002-4452-934X
Sanda BocaInstitute for Interdisciplinary Research in Bio-Nano-Sciences, Babeş-Bolyai University, 42 T. Laurian Str., 400271 Cluj-Napoca, Romania.ORCID 0000-0002-9369-3488
Alexandra FalamasNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Str., 400293 Cluj-Napoca, Romania.
Nicoleta TosaNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Str., 400293 Cluj-Napoca, Romania.ORCID 0000-0002-4097-0656
Ioana Andreea BrezeşteanNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Str., 400293 Cluj-Napoca, Romania.
Attila BendeNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Str., 400293 Cluj-Napoca, Romania.ORCID 0000-0002-5347-1514
Lucian Barbu-TudoranNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Str., 400293 Cluj-Napoca, Romania.
Rebeca MoldovanAnalytical Chemistry Department, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 4, Louis Pasteur, 400349 Cluj-Napoca, Romania.
Ede BodokiAnalytical Chemistry Department, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 4, Louis Pasteur, 400349 Cluj-Napoca, Romania.ORCID 0000-0003-4667-2286
Cosmin FarcǎuNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Str., 400293 Cluj-Napoca, Romania.ORCID 0000-0001-8602-0771
National Institute for Research and Development of Isotopic and Molecular Technologies · ROBabeș-Bolyai University · ROIuliu Hațieganu University of Medicine and Pharmacy · RO

Funding

Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii PN-III-P2-2.1-PED-2019-5473
6 · The paper itself

Abstract

The increasing pollution of surface and groundwater bodies by pharmaceuticals is a general environmental problem requiring routine monitoring. Conventional analytical techniques used to quantify traces of pharmaceuticals are relatively expensive and generally demand long analysis times, associated with difficulties in performing field analyses. Propranolol, a widely used β-blocker, is representative of an emerging class of pharmaceutical pollutants with a noticeable presence in the aquatic environment. In this context, we focused on developing an innovative, highly accessible analytical platform based on self-assembled metal colloidal nanoparticle films for the fast and sensitive detection of propranolol based on Surface Enhanced Raman Spectroscopy (SERS). The ideal nature of the metal used as the active SERS substrate was investigated by comparing silver and gold self-assembled colloidal nanoparticle films, and the improved enhancement observed on the gold substrate was discussed and supported by Density Functional Theory calculations, optical spectra analyses, and Finite-Difference Time-Domain simulations. Next, direct detection of propranolol at low concentrations was demonstrated, reaching the ppb regime. Finally, we showed that the self-assembled gold nanoparticle films could be successfully used as working electrodes in electrochemical-SERS analyses, opening the possibility of implementing them in a wide array of analytical applications and fundamental studies. This study reports for the first time a direct comparison between gold and silver nanoparticle films and, thus, contributes to a more rational design of nanoparticle-based SERS substrates for sensing applications.

Indexed as

GoldMetal NanoparticlesPharmaceutical PreparationsPropranololSilverSpectrum Analysis, RamanGoldPharmaceutical PreparationsPropranololSilverDFT calculationsself-assembled nanoparticle filmssurface-enhanced Raman spectroscopyβ-blocker propranolol

Identifiers

PMID37232891
PMCPMC10216585
OpenAlexW4376115670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.